AN ACT relating to pharmaceutical manufacturers.
Summary
Create a new section of KRS Chapter 315 to define terms, prohibit discrimination against 340B covered entities by pharmaceutical manufacturers, and authorize the Attorney General to investigation violations.
Bill status
passed
3 of 5 stages cleared
Introduction
Jan 2024
Committee Review
Mar 2024
Senate Passage
Mar 2024
House Passage
Governor
Introduced Jan 2, 2024
Last action Mar 12, 2024
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
10
Key actions
2
Committee
5
Mar 12, 2024
Committee
to Health Services (H)
lower
Mar 12, 2024
Committee
to Committee on Committees (H)
lower
Mar 8, 2024
Upper · Passed
3rd reading, passed 32-5 with Committee Substitute (1) and Committee Amendment (1-title)
upper
Feb 21, 2024
Upper · Passed
reported favorably, 1st reading, to Calendar with Committee Substitute (1) and Committee Amendment (1-title)
upper
Jan 3, 2024
Committee
to Health Services (S)
upper
Jan 2, 2024
Committee
to Committee on Committees (S)
upper
Jan 2, 2024
Introduced
introduced in Senate
upper
3 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Karen Berg
DDemocratic
P
Matt Deneen
RRepublican
P
Steve Meredith
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 27
Scope: KY
Hi! I can help you understand SB 27. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline